Towards personalized therapy for patients with glioblastoma. - Wikidata - awgldk - TriplyDB

Towards personalized therapy for patients with glioblastoma.

Towards personalized therapy for patients with glioblastoma.

http://www.wikidata.org/entity/Q34978252

about

A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1.IQGAP1‑siRNA inhibits proliferation and metastasis of U251 and U373 glioma cell lines Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.Mechanism of temozolomide-induced antitumour effects on glioma cells.Tumor growth analysis by magnetic resonance imaging of the C6 glioblastoma model with prospects for the assessment of magnetohyperthermia therapy.Multiscale design of cell-type-specific pharmacokinetic/pharmacodynamic models for personalized medicine: application to temozolomide in brain tumors.FM19G11 inhibits O6 -methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions.MicroRNA-650 expression in glioma is associated with prognosis of patients.

P2860

Q36449844-5C81A8E1-551E-4752-BAF8-CBDABCBF49D1 Q38713809-114A3A32-DEB5-4BF2-834B-3E1846884DD8 Q38891614-B5BB827F-FAA2-4E5D-A6A9-5F14EF0DA785 Q38943486-416FC54A-C0EA-4815-A916-C13E5F3CD399 Q39044642-F775348B-CE3F-480D-9D33-F204C607FA35 Q39263838-5CE121A3-5092-4BAB-AD9E-A3A7FD74C7FD Q39475989-EB9966B3-43E1-4CE7-9042-407AA84D2F18 Q53682260-2AD581D3-422E-4004-9FB7-17E32FA08846 Q55461471-448A801D-055C-4AD4-91CD-3BCA408F36DD

P2860

Towards personalized therapy for patients with glioblastoma.

http://www.wikidata.org/entity/Q34978252

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Towards personalized therapy for patients with glioblastoma.

@ast

Towards personalized therapy for patients with glioblastoma.

@en

Towards personalized therapy for patients with glioblastoma.

@nl

type

label

Towards personalized therapy for patients with glioblastoma.

@ast

Towards personalized therapy for patients with glioblastoma.

@en

Towards personalized therapy for patients with glioblastoma.

@nl

prefLabel

Towards personalized therapy for patients with glioblastoma.

@ast

Towards personalized therapy for patients with glioblastoma.

@en

Towards personalized therapy for patients with glioblastoma.

@nl

P1433

Q34978252-69080C89-CE27-462F-AA28-EC9A6D898E65

P1476

Q34978252-14C76BFD-A9FC-4DBB-B0F2-8ED2BB1DC1D7

P2093

Q34978252-6455008F-AE52-4833-92D6-5E1213BCE791

Q34978252-9FDB59C7-4B39-4E99-901D-93E2304C174A

P2860

Q34978252-0325E6F9-BE8D-484A-B313-B2E3002116FF

Q34978252-03F7A5A3-2A1F-4838-925E-76780A5F6F34

Q34978252-066B926F-53B4-496C-9C33-E7F8839E813A

Q34978252-09CA746A-7D48-4461-8E70-F75AE84BFAC7

Q34978252-12F66A27-316E-42C3-83BB-27D3CF59A40A

Q34978252-1CCF6C63-6DDE-4D8A-AD81-7E5FB9035A4A

Q34978252-1DF43081-0457-4459-9616-01A444442623

Q34978252-20339991-A71D-4CB2-8ACA-59DF347914E9

Q34978252-21B44ADB-5CDC-4689-9687-05294139C22E

Q34978252-21B98746-B92A-4077-9A84-10AA631F4091

P304

Q34978252-901503FF-DDE6-452B-AF01-BF678B8C6960

P31

Q34978252-8CBEF13A-D33B-497C-BAFA-EB76FBD820F9

P356

Q34978252-94BCCADF-BC11-4CE4-ADF9-BA53BA0C7870

P433

Q34978252-86E27300-035E-458F-BDE2-B3567B5F071B

P478

Q34978252-33E883D0-4A96-4ED5-AFFA-17E2196F8103

P577

Q34978252-AE4B6BF9-1F5B-4EAB-A5FA-6E68ABC70337

P698

Q34978252-1C1003DB-CE4A-41ED-9A56-50167BE1DE17

P932

Q34978252-EC90781A-925B-457E-8A1F-D714B31B69B6

P356

P1433

Expert Review of Anticancer Therapy

P1476

Towards personalized therapy for patients with glioblastoma.

@en

P2093

Arnab Chakravarti

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Shirai

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

The biology of VEGF and its receptors

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

P304

1935-1944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.11.103

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22117160

http://www.w3.org/2001/XMLSchema#string

P932

4297206

http://www.w3.org/2001/XMLSchema#string